Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jan;22(1):28-36.
doi: 10.1007/s00467-006-0310-4. Epub 2006 Nov 16.

Therapeutic approach to FSGS in children

Debbie S Gipson  1 , Keisha Gibson, Patrick E Gipson, Sandra Watkins, Marva Moxey-Mims
Affiliations
Review

Therapeutic approach to FSGS in children

Debbie S Gipson et al. Pediatr Nephrol. 2007 Jan.

Abstract

Therapy of primary focal segmental glomerulosclerosis (FSGS) in children incorporates conservative management and immunosuppression regimens to control proteinuria and preserve kidney function. In long-term cohort studies in adults and children with primary FSGS, renal survival has been directly associated with degree of proteinuria control. This educational article reviews the current therapeutic approach toward children with primary FSGS.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
a Kaplan–Meyer analysis of the risk of end-stage renal disease (ESRD) by proteinuria remission status in children with primary focal segmental glomerulosclerosis (FSGS). b Kidney survival by proteinuria remission status in adults with primary FSGS. CR complete remission, PR partial remission, NR no remission
See this image and copyright information in PMC

References

    1. Benchimol C. Focal segmental glomerulosclerosis: pathogenesis and treatment. Curr Opin Pediatr. 2003;15:171–180. - PubMed
    1. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol. 2005;16:1061–1068. - PubMed
    1. Gipson DS, Chin H, Presler TP, Jennette C, Ferris ME, Massengill S, Gibson K, Thomas DB. Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol. 2006;21:344–349. - PubMed
    1. Cattran DC, Rao P. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis. 1998;32:72–79. - PubMed
    1. Caridi G, Bertelli R, Carrea A, Di Duca M, Catarsi P, Artero M, Carraro M, Zennaro C, Candiano G, Musante L, Seri M, Ginevri F, Perfumo F, Ghiggeri GM. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol. 2001;12:2742–2746. - PubMed

MeSH terms